Treatment of atopic dermatitis with upadacitinib: adcare single center experience

IntroductionThe role of upadacitinib in the management of moderate to severe atopic dermatitis seems promising, but more data on its efficacy and safety are needed. This study endeavors to assess the practical impact and safety of upadacitinib in patients with moderate to severe atopic dermatitis. T...

Descripción completa

Detalles Bibliográficos

Autores principales:	Daria S. Fomina, Olga A. Mukhina, Valeria I. Mikhailova, Marina S. Lebedkina, Elizaveta L. Sedova, Elena N. Bobrikova, Olga G. Elisyutina, Elena S. Fedenko, Tair T. Nurpeisov, Alexander V. Karaulov, Mar’yana A. Lysenko, Luis Felipe C. Ensina
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2024-04-01
Colección:	Frontiers in Medicine
Materias:	upadacitinib atopic dermatitis drug efficacy and safety Eczema Area and Severity Index Janus kinase inhibitors molecules
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1385720/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!